Global Point-of-Care (POC) Coagulation Testing Devices Market Projected to Surpass $3.36 Billion by 2029 with 9.7% Annual Growth

What Are the Market Size and Growth Forecast for the Point-of-Care (POC) Coagulation Testing Devices Market?
In recent times, the market size for point-of-care (POC) coagulation testing devices has seen robust growth. The market is projected to expand from $2.12 billion in 2024 to $2.33 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. The expansion during the historical period can be credited to the rising occurrence of infectious and chronic diseases, an influx in the elderly population, the extensive use of compact portable instruments, growing implementation of biomarker profiling, and the increasing demand for tailored medical care.

In the coming years, the market size of point-of-care (POC) coagulation testing devices is projected to experience significant growth. It is expected to expand to $3.36 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.7%. This anticipated surge during the projection period can be linked to an increased demand for swift and precise disease diagnosis. It is also due to the growing stress on wellness and preventive healthcare, an increase in requirements for speedy on-site diagnostic testing, a rise in contagious disease outbreaks, and the expansion of telemedicine. Key trends during this forecast period will be the integration of next-generation sequencing (NGS), RNA detection and evaluation, single-cell PCR investigation, bioinformatics software and analysis tools, microfluidic technologies, lab-on-a-chip systems, point-of-care testing (POCT), along with the advancement in artificial intelligence (AI) and data analytics.

What Is Contributing to the Growth of the Point-of-Care (POC) Coagulation Testing Devices Market?
An increase in the incidence of blood clotting disorders is anticipated to spur the expansion of the point-of-care (POC) coagulation testing devices market. Blood clotting issues hinder the blood's ability to clot adequately. Various lifestyle determinants, such as smoking, high alcohol intake, and a lack of physical activity, can contribute to these disorders. These factors can affect blood vessel health, levels of clotting factors and blood flow, escalating the chances of irregular clot formation. POC coagulation testing devices empower healthcare professionals to swiftly ascertain a patient's coagulation state, facilitating rapid alterations to medication dosages and treatment strategies. For example, in October 2023, the yearly global survey by the World Federation of Hemophilia, a non-profit organization based in Canada, revealed that 427,685 individuals in 2022 suffered from bleeding disorders. This figure includes 257,146 people with hemophilia, with 208,957 having Hemophilia A, 42,203 having Hemophilia B, and 5,986 with an unidentified type of hemophilia. Moreover, an additional 70,034 individuals have other types of bleeding disorders. Thus, the increasing incidence of blood clotting disorders is triggering the growth of the point-of-care (POC) coagulation testing devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp

Which Key Market Leaders Are Driving Point-of-Care (POC) Coagulation Testing Devices Industry Growth?
Major companies operating in the point-of-care (POC) coagulation testing devices market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healthcare Limited, Color Health Inc., LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd., Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.

What Are the Emerging Trends in the Point-of-Care (POC) Coagulation Testing Devices Industry?
Major corporations in the point-of-care (POC) coagulation testing apparatus industry are utilizing immunofluorescence-based quantitative analyzers to enhance diagnosis and management of coagulation irregularities. These diagnostic tools, used in labs, help measure and assess certain proteins or molecules involved in the coagulation procedure, thus aiding in detecting and managing blood clotting disorders. As an example, in January 2023, the India-based pharmaceutical firm, Cipla Limited, introduced Cippoint. This analyzer applies immunofluorescence technology to render fast and precise results within 3 to 15 minutes, thus speeding up the clinical decision-making process. The easy-to-use interface, rapid processing time, and widely ranging test abilities make Cippoint instrumental in boosting diagnostic proficiency, making timely clinical decisions feasible, and enhancing patient care results.

What Are the Main Segments in the Point-of-Care (POC) Coagulation Testing Devices Market?
The point-of-care (POC) coagulation testing devices market covered in this report is segmented -

1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users

Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report

Which Geographic Area Leads the Point-of-Care (POC) Coagulation Testing Devices Market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Point-of-Care (POC) Coagulation Testing Devices Global Market Report?

- Market Size Analysis: Analyze the Point-of-Care (POC) Coagulation Testing Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Point-of-Care (POC) Coagulation Testing Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Point-of-Care (POC) Coagulation Testing Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Point-of-Care (POC) Coagulation Testing Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15636

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.